Investments In HNB And Atomization Technologies Will Expand Future Opportunities

Key Takeaways

• Enhancing management quality and R&D investments in high-growth areas like HNB are likely to boost productivity, effectiveness, and future revenue growth.
  
• Expanding technological advancements and aligning with regulations in key markets may stabilize and increase market presence and revenue growth potential.
  
• Volatile government policies, customer reliance, and rising expenses pose risks, while R&D in new areas may impact short-term earnings without immediate returns.

Catalysts

An investment holding company, engages in the provision of vaping technology solutions.

• Smoore is enhancing its management quality and organizational efficiency through stock incentives, performance management, and departmental restructurings, likely improving productivity and effectiveness which can positively impact net margins.
  
• The company is strategically investing in R&D for high-growth areas such as Heat-Not-Burn (HNB) products, beauty atomization, inhalation therapy, and special purpose atomization, which are expected to drive future revenue growth as these segments mature.
  
• Smoore's self-branded products, especially in the open system segments, have shown strong market presence and brand reputation, providing potential for increased market share and revenue growth.
  
• The company is building on its technological advancements in HNB products, aligning with customer requirements and expanding production capacities, which may lead to significant revenue and earnings growth.
  
• Smoore is taking advantage of regulatory developments in Europe and the U.S. to adapt and develop compliant products, which could stabilize and grow its market presence, supporting future revenue streams.

Smoore International Holdings Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• Analysts are assuming Smoore International Holdings's revenue will grow by 15.0% annually over the next 3 years.
• Analysts assume that profit margins will increase from 7.5% today to 10.8% in 3 years time.
• Analysts expect earnings to reach CN¥2.3 billion (and earnings per share of CN¥0.38) by about May 2029, up from CN¥1.1 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as CN¥2.8 billion.
• In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 41.2x on those 2029 earnings, down from 53.1x today. This future PE is lower than the current PE for the HK Tobacco industry at 53.1x.
• Analysts expect the number of shares outstanding to grow by 0.11% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 7.77%, as per the Simply Wall St company report.

Risks

• The volatile nature of government policies concerning e-cigarettes, especially disposables, poses a significant risk to Smoore's revenue stability due to potential market restrictions or bans.
  
• Heavy reliance on a few key customers, such as BAT, creates a risk of business volatility, which could severely affect Smoore's revenue if these partnerships change or terminate.
  
• Increasing marketing and administrative expenses, as noted by the CFO, could impact net margins unless revenue grows significantly in tandem with these costs.
  
• A decline in gross margin from 38.7% to 37.4% signals potential cost pressures or increased competition impacting profitability.
  
• Focus on expanding into emerging businesses like beauty atomization and inhalation therapy involves significant R&D investments, which may not yield immediate returns, impacting short-term earnings.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The analysts have a consensus price target of HK$14.25 for Smoore International Holdings based on their expectations of its future earnings growth, profit margins and other risk factors.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of HK$21.05, and the most bearish reporting a price target of just HK$7.91.
• In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be CN¥21.7 billion, earnings will come to CN¥2.3 billion, and it would be trading on a PE ratio of 41.2x, assuming you use a discount rate of 7.8%.
• Given the current share price of HK$10.48, the analyst price target of HK$14.25 is 26.5% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.